XML 86 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Depreciation expense $ 10,276 $ 2,376 $ 27,185 $ 12,793  
Research and Development Cost 424,579 $ 317,573 1,526,294 $ 945,443  
Unbilled receivables 1,721,147   1,721,147   $ 1,494,553
Revenue receive as consideration     $ 812,000    
Short term lease term     12 days    
Costs and expenses     $ 68,000    
Operations and maintenance expense     574,000    
Cash and cash equivalents 1,960,375   1,960,375   10,445,404
Capitalized of costs 99,245   99,245    
Inventory allowance     50,000   0
Contract loss provision     $ 600,000   500,000
Share based description     cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce its forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year    
Options [Member]          
Antidilutive Excluded from Computation of Earnings Per Share, Amount     17,207,510 10,628,000  
Unvested Restricted Stock [Member]          
Antidilutive Excluded from Computation of Earnings Per Share, Amount     3,053,742    
Warrants [Member]          
Antidilutive Excluded from Computation of Earnings Per Share, Amount     1,235,000 1,235,000  
One Customer [Member] | Revenue [Member]          
Unbilled receivables $ 1,721,147   $ 1,721,147   $ 1,494,553
Concentrations of Credit Risk       96.00%  
Account receivable balance     $ 288,777    
Two Customer [Member] | Revenue [Member]          
Concentrations of Credit Risk     80.00%